Expert selections of important viral hepatitis data from EASL 2022, including studies of patients with HBV, HDV (hepatitis delta virus), and HCV, from Clinical Care Options (CCO)
Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who had end-stage liver failure from a missed HCV diagnosis
Clinical Care Options (CCO) commentary from Oluwaseun Falade-Nwulia, MBBS, MPH, on the need for integrating HCV services into addiction medicine settings
Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who has lived with and been cured of HCV infection
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.